American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Friday's optimism in Wall Street brought cheer to the Nifty and Sensex in the Monday morning trade, as bulls took over the ...

TAIPEI, March 18, 2025 /PRNewswire/ -- TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a ...

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...

The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Governments and global health groups are working to try to fill the most urgent gaps in the fight against diseases such as ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Domestic stock indices saw minor gains on Monday, buoyed by receding fears of a US government shutdown and anticipation of the US Federal Reserve's upcoming policy review. The Nifty closed just above ...